Cytokinetics | CYTK - Operating Expenses


Cytokinetics reported $168.69M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 242.88M 10.68M Sep/2025
Amgen USD 5.9B 773M Dec/2025
Arca Biopharma USD 25.09M 5.23M Mar/2025
Bayer EUR 10.2B 523M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Brainstorm Cell Therapeutics USD 3.09M 100K Mar/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Capricor Therapeutics USD 24.98M 6.15M Mar/2025
Cytokinetics USD 168.69M 9.58M Sep/2025
Eisai JPY 199.9B 16.22B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Exelixis USD 362.75M 21.35M Dec/2025
Geron USD 61.11M 376K Sep/2025
Halozyme Therapeutics USD 211.07M 74.73M Dec/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
Ligand Pharmaceuticals USD 8.29M 32.17M Sep/2025
Merck USD 10.16B 558M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025